Aro Biotherapeutics Co — Form D

Aro Biotherapeutics Co of PHILADELPHIA, PA, a company, filed a Form D exempt-offering notice with the SEC on 2019-04-15. The offering totals $4.9M, of which $3.5M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (23)

NameRoleLocation
Elizabeth AndersonRelated PersonPhiladelphia, PA
Susan B DillonRelated PersonPhiladelphia, PA
Mark V. LaurenziRelated PersonPhiladelphia, PA
Karyn O'NeilRelated PersonPhiladelphia, PA
Bruce PeacockRelated PersonPhiladelphia, PA
Christopher B MirabelliDirectorPhiladelphia, PA
Susan B DillonDirectorPhiladelphia, PA
Susan B DillonExecutive OfficerPhiladelphia, PA
Scott B GreenbergExecutive OfficerPhiladelphia, PA
Karyn B O'NeilDirectorPhiladelphia, PA
Karyn B O'NeilExecutive OfficerPhiladelphia, PA
Marten B SteenDirectorPhiladelphia, PA
Bruce B PeacockDirectorPhiladelphia, PA
Elizabeth B AndersonDirectorPhiladelphia, PA
Daniel B JanseDirectorPhiladelphia, PA
Mark B LaurenziExecutive OfficerPhiladelphia, PA
Kevin B RaidyDirectorPhiladelphia, PA
Mittie B DoyleExecutive OfficerPhiladelphia, PA
Jess B LiftonDirectorPhiladelphia, PA
Saan-Chirag B GandhiDirectorPhiladelphia, PA
Mark V LaurenziExecutive OfficerPhiladelphia, PA
Elizabeth V AndersonDirectorPhiladelphia, PA
Bruce V PeacockDirectorPhiladelphia, PA

Other filings by this issuer (6)

FiledFormOfferingSold
2022-12-28D$100.0M$24.0M
2021-12-16D/A$90.3M$90.3M
2021-06-11D/A$90.3M$64.3M
2021-04-16D/A$90.3M$44.8M
2021-01-05D$90.3M$42.3M
2020-01-06D$5.0M$5.0M

More